All physicians are faced with the challenge of how to help patients with no approved therapies for their diseases. What are ...

For the first time, the FDA will consider whether to approve a trio of drugs for tiny patient populations based on trials ...

The future of medicine may very well lie in the personalization of health care—knowing exactly what an individual needs and ...

There is growing enthusiasm about China’s potential to speed up drug development with AI. And companies outside the country ...

Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has announced the creation of its new Scientific Advisory Board (SAB), marking a ...

The global immunohistochemistry (IHC) market is expected to grow from USD 3.5 billion in 2024 to USD 7.4 billion by 2034, reflecting a CAGR of 7.8% over the forecast period. Request a Sample Copy of ...

Dewpoint Therapeutics’ second development candidate, DPTX3496 is an oral, small molecule acting via a novel condensate-modulating mechanism of ...

The number and proportion of people aged 60 years and older in the population is increasing. This number is projected to ...

Genialis, the RNA biomarker company, today announced an extension of its collaboration with Debiopharm, a Swiss-based ...

Researchers designed oligopeptides that could co-assemble with therapeutic cargoes to create nanoparticles that improved the ...